Recipient of federal assistance
KENYA MEDICAL RESEARCH INSTITUTE
KENYA MEDICAL RESEARCH INSTITUTE received $11.8M in federal grants and other assistance in FY2026, on 15 actions, +1,035% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $42.3M. Its largest awarding agency was Defense Health Agency ($10.4M).
- Assistance · FY2026
- $11.8M
- New awards
- 1
- Actions
- 15
- Since FY2021
- $42.3M
- UEI
- HM2ZJJBEKYM4
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
Assistance by fiscal year
- 7.8MFY2021
- 6.8MFY2022
- 3.9MFY2023
- 10.9MFY2024
- 1MFY2025
- 11.8MFY2026
By type
- Grants$11.8M100%
Top programs · Awarding agencies
Obligations in FY2026.
Top programs
- 12.420 · Military Medical Research and Development$10.4M88%
- 93.989 · International Research and Research Training$553.1K4.7%
- 93.393 · Cancer Cause and Prevention Research$537.3K4.6%
- 93.242 · Mental Health Research Grants$100K0.8%
- 93.855 · Allergy and Infectious Diseases Research$95K0.8%
- 93.399 · Cancer Control$85.1K0.7%
- 93.310 · Trans-NIH Research Support$50K0.4%
Awarding agencies
- Defense Health Agency$10.4M88%Department of Defense
- National Institutes of Health$1.4M12%Department of Health and Human Services
Largest awards
- 12.420 · Military Medical Research and Development· Defense Health Agency· Cooperative agreement· Jan 7, 2021 – Jun 4, 2026· W81XWH1320041
- 93.310 · Trans-NIH Research Support· National Institutes of Health· Project grant· Nov 9, 2020 – Aug 11, 2026· D43TW009783
- 93.989 · International Research and Research Training· National Institutes of Health· Project grant· Feb 25, 2021 – Jan 28, 2026· D43TW008650
- 93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· May 6, 2021 – Sep 7, 2026· R25TW010509
- 93.399 · Cancer Control· National Institutes of Health· Cooperative agreement· Sep 19, 2023 – Sep 17, 2026· UG1CA285132
- 93.393 · Cancer Cause and Prevention Research· National Institutes of Health· Project grant· Aug 31, 2026 – Aug 31, 2026· R01CA318829
Subawards
Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.
As a prime: who it pays · FY2026
No subawards reported as a prime in FY2026.
As a sub-recipient: who pays it · FY2026
- Sub-grants: $3.4M (21 subawards)
13 primes
- UNIVERSITY OF WASHINGTON$785.5K23%SEATTLE, WA · 4 subawards
- BETHESDA, MD · 2 subawards
- EMORY UNIVERSITY$282.9K8.2%ATLANTA, GA · 2 subawards
- DUKE UNIVERSITY$279.4K8.1%DURHAM, NC · 2 subawards
- SAN FRANCISCO, CA · 2 subawards
- THE REGENTS OF THE UNIVERSITY OF COLORADO$246.2K7.2%AURORA, CO · 1 subaward
- BROWN UNIVERSITY$208.9K6.1%PROVIDENCE, RI · 1 subaward
- OHIO STATE UNIVERSITY, THE$172.9K5.0%COLUMBUS, OH · 2 subawards
- WASHINGTON UNIVERSITY, THE$122.2K3.6%SAINT LOUIS, MO · 1 subaward
- TRUSTEES OF INDIANA UNIVERSITY$121.2K3.5%INDIANAPOLIS, IN · 1 subaward
By fiscal year
- FY2021: $40.8K paid out · $14.6M received
- FY2022: $0 paid out · $20.4M received
- FY2023: $0 paid out · $6.8M received
- FY2024: $0 paid out · $3.9M received
- FY2025: $0 paid out · $6.2M received
- FY2026: $0 paid out · $3.4M received
Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.
Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from FY2021.
Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2021–FY2026.